🇺🇸 Coumarin/troxerutin in United States

39 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 5 reports (12.82%)
  2. Malaise — 5 reports (12.82%)
  3. Vomiting — 5 reports (12.82%)
  4. Abdominal Pain — 4 reports (10.26%)
  5. Pain — 4 reports (10.26%)
  6. Pain In Extremity — 4 reports (10.26%)
  7. Blood Pressure Increased — 3 reports (7.69%)
  8. Cardiovascular Disorder — 3 reports (7.69%)
  9. Diarrhoea — 3 reports (7.69%)
  10. Drug Ineffective — 3 reports (7.69%)

Source database →

Other Cardiovascular / Vascular approved in United States

Frequently asked questions

Is Coumarin/troxerutin approved in United States?

Coumarin/troxerutin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Coumarin/troxerutin in United States?

Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.